Matrix metalloproteinases 2 and 9 are dispensable for pancreatic islet formation and function in vivo.
Pancreatic islet formation is a highly regulated process that is initiated at the end of gestation in rodents. Endocrine precursor cells first form within the epithelium of duct-like structures and then delaminate from the epithelium, migrate, and cluster during the early stages of islet formation. The molecular mechanisms that regulate endocrine cell migration and islet formation are not well understood. Cell culture studies suggest that matrix metalloproteinases (MMPs) 2 and 9 are required for islet formation. To address whether MMP2 and MMP9 function are essential for endocrine cell migration and islet formation in vivo, we analyzed pancreas development in MMP2/MMP9 double-deficient mice. Our results show that islet architecture and function are unperturbed in these knockout mice, demonstrating that both MMP2 and MMP9 functions are dispensable for islet formation and endocrine cell differentiation. Our studies also show that a number of other MMPs are expressed at the time islet formation is initiated. This observation suggests that other MMPs may substitute for MMP2 and MMP9 loss in pancreatic tissue. However, islet formation is unaffected in transgenic mice with modified tissue inhibitor of metalloproteinase-1 (TIMP1) levels, suggesting that MMP activity may contribute little to islet morphogenesis in vivo.
Perez
Sabina E
SE
Diabetes Center, Department of Medicine, University of California, San Francisco, California, 94143-0573, USA.
Cano
David A
DA
Dao-Pick
Trang
T
Rougier
Jean-Phillipe
JP
Werb
Zena
Z
Hebrok
Matthias
M
D000818:Animals; D002454:Cell Differentiation; D015870:Gene Expression; D007515:Islets of Langerhans / Q000502:physiology*; D020778:Matrix Metalloproteinase 2 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D020780:Matrix Metalloproteinase 9 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D013997:Time Factors; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000235:genetics / Q000378:metabolism
D019715:Tissue Inhibitor of Metalloproteinase-1; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9
J Cell Biol. 2000 Sep 18;150(6):1445-60
10995448
Genes Dev. 2000 Sep 1;14(17):2123-33
10970876
Genes Dev. 2001 Jan 15;15(2):111-27
11157769
Mol Biol Cell. 2001 May;12(5):1457-66
11359935
Annu Rev Cell Dev Biol. 2001;17:463-516
11687497
Am J Physiol Renal Physiol. 2002 Mar;282(3):F541-52
11832437
J Cell Sci. 2002 Oct 1;115(Pt 19):3719-27
12235282
J Cell Biol. 2003 Sep 15;162(6):1123-33
12975354
Dev Cell. 2003 Nov;5(5):695-707
14602071
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2924-9
14970313
Dev Biol. 1986 Jan;113(1):201-6
3002886
Development. 1991 Aug;112(4):1115-21
1682130
J Biol Chem. 1992 Apr 15;267(11):7856-62
1373140
J Cell Biol. 1992 Aug;118(3):727-39
1639854
Curr Biol. 1994 Aug 1;4(8):676-86
7953553
Development. 1995 Jun;121(6):1569-80
7600975
Oncogene. 1996 Dec 5;13(11):2307-14
8957071
J Cell Biol. 1996 Dec;135(6 Pt 1):1669-77
8978831
Mod Pathol. 1997 Jan;10(1):47-54
9021726
Biochem J. 1997 Mar 15;322 ( Pt 3):809-14
9148753
J Cell Biol. 1997 Mar 24;136(6):1363-73
9087449
J Biol Chem. 1997 Sep 5;272(36):22389-92
9278386
Cell. 1997 Nov 14;91(4):439-42
9390552
J Periodontal Res. 1998 Jan;33(1):65-72
9524323
Cell. 1998 May 1;93(3):411-22
9590175
Cold Spring Harb Symp Quant Biol. 1997;62:377-83
9598372
J Cell Biol. 1998 Nov 2;143(3):827-36
9813100
Biochim Biophys Acta. 2000 Mar 7;1477(1-2):267-83
10708863
Development. 2000 Jun;127(12):2617-27
10821760
Development. 2000 Nov;127(22):4905-13
11044404